Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Status:
Terminated
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, double-blinded, placebo-controlled study is to test the
hypothesis that administration of aprepitant will decrease the severity of pruritus in
patients with Sèzary Syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center